Long acting growth hormone is expected to increase adult anti-aging indications
-
Last Update: 2014-03-22
-
Source: Internet
-
Author: User
Search more information of high quality chemicals, good prices and reliable suppliers, visit
www.echemi.com
It is understood that the preclinical detection of the indication has been completed, and Kinsey pharmaceutical will apply to the State Food and Drug Administration for the third phase of clinical trial Because it is to add new indications, only phase 3 clinical trial is needed, which will take about 1 year to complete The polyethylene glycol recombinant human growth hormone injection declared by Changchun Jinsai Pharmaceutical Co., Ltd obtained the first production approval document of biological preparation in 2014 with the approval number of "s20140001" At present, Changchun Jinsai Pharmaceutical Co., Ltd is the first enterprise in China to obtain the approval for the production of polyethylene glycol recombinant human growth hormone injection, while the products declared by its competitors, Anke biology and Xiamen Tebao, a subsidiary of Tonghua Dongbao Co., Ltd., are still in the clinical trial stage In recent years, the sales volume of recombinant human growth hormone products in China has maintained a steady growth year by year It is estimated that the market scale of recombinant human growth hormone in China will reach about 2.23 billion yuan by 2015 The recombinant human growth hormone after PEGylation can prolong the action time of the drug and improve the therapeutic effect accordingly The market potential in the future can not be ignored.
This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only.
This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of
the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed
description of the concern or complaint, to
service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content
will be removed immediately.
